0001225208-12-022233.txt : 20121102 0001225208-12-022233.hdr.sgml : 20121102 20121102141215 ACCESSION NUMBER: 0001225208-12-022233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121101 FILED AS OF DATE: 20121102 DATE AS OF CHANGE: 20121102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reininger Cornelia CENTRAL INDEX KEY: 0001559878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 121176243 MAIL ADDRESS: STREET 1: 425 METRO PLACE NORTH SUITE 425 CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 425 METRO PLACE NORTH STREET 2: SUITE 300 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 425 METRO PLACE NORTH STREET 2: SUITE 300 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 doc4.xml X0306 4 2012-11-01 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001559878 Reininger Cornelia 425 METRO PLACE NORTH SUITE 450 DUBLIN OH 43017 1 SVP & Chief Medical Officer Stock Option (Right to Buy) 2.8500 2012-11-01 4 A 0 88000.0000 0.0000 A 2022-11-01 Common Stock 88000.0000 88000.0000 D Option vests 25% per year beginning on the first anniversary of the date of grant. William J. Kelly, Jr., Attorney-In-Fact 2012-11-02